US Court Blocks Overseas Drug Imports
A US court decided that companies cannot bring Gilead medicines from other countries, impacting health programs.
A big decision just came from a US court. It says that certain health programs cannot bring Gilead Sciences' medicines into the country from overseas. This ruling means a lot for how people get some of their drugs.
These health programs are known as Alternative Funding Programs. They helped patients get medicines, often from other countries, at lower costs. Gilead Sciences, a major drug company, took action against these programs.
The appeals court sided with Gilead Sciences. This decision stops the flow of these imported medicines. Patients who used these programs might now face higher costs or need to find new ways to get their medications.
This ruling changes how certain drugs are supplied in the US. It could impact many people who rely on these programs for important medicines.
Source: CNBC
More from Biotech
